home / stock / adil / adil news

ADIL News and Press, Adial Pharmaceuticals Inc From 10/09/25

Stock Information
Company Name: Adial Pharmaceuticals Inc
Stock Symbol: ADIL
Market: NASDAQ
Website: adialpharma.com
Menu
ADIL ADIL Quote ADIL Short ADIL News ADIL Articles ADIL Message Board
Get ADIL Alerts

News, Short Squeeze, Breakout and More Instantly...
ADIL - Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution

GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorder...
ADIL - Adial Pharmaceuticals Provides Business Update Following Favorable Comments from FDA End-of-Phase 2 (EOP2) Meeting for AD04

GLEN ALLEN, Va., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorde...

ADIL - Adial Pharmaceuticals Granted a 180 Calendar Day Extension by Nasdaq to Regain Compliance with the Minimum Bid Price Rule

GLEN ALLEN, Va., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorde...

ADIL - Adial Pharmaceuticals reports Q2 results

2025-08-14 11:14:40 ET More on Adial Pharmaceuticals Adial Pharmaceuticals announces pricing of $3.6M public offering Seeking Alpha’s Quant Rating on Adial Pharmaceuticals Historical earnings data for Adial Pharmaceuticals Financial information for Adi...
ADIL - Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

GLEN ALLEN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders,...

ADIL - Expected US Company Earnings on Tuesday, August 12th, 2025

Reeds Inc. (REED) is expected to report $-0.04 for Q2 2025 Jerash Holdings (US) Inc. (JRSH) is expected to report for Q1 2026 Churchill Capital Corp IX (CCIX) is expected to report for quarter end 2025-06-30 Verde Clean Fuels Inc. (VGAS) is expected to report for Q2 2025 Mobile In...

ADIL - Expected earnings - Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc (ADIL) is expected to report $-0.22 for Q2 2025
ADIL - Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting

Meeting Completion Marks Major Step Toward Phase 3 AD04 Trial Launch Strategic Partnership Discussions Expected Following the Positive FDA Meeting GLEN ALLEN, Va., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the ȁ...

ADIL - PRISM Mid-Day Movers: Streaming Momentum and Fitness Product Turnaround Drive Consumer Strength

2025-07-30 14:30:42 ET FuboTV Pops 22% on Strong Q2 Results and First Positive EBITDA FuboTV Inc. ( FUBO ) soared 22.03%, leading the PRISM Emerging Sports Index , after releasing upbeat preliminary Q2 2025 results . The streaming platform exceeded revenue and subscriber...

ADIL - PRISM Mid-Day Movers: Space Sector Offerings and EV Earnings Diverge Indices

2025-07-28 14:30:40 ET Sidus Space Falls 41% Following $7.5M Public Offering Announcement Sidus Space, Inc. ( SIDU ) plummeted 41.33%, dragging down the PRISM Emerging Space Index , after pricing a $7.5 million public offering of 7.14 million shares at $1.05 each . The off...
Previous 10 Next 10